Implementation of new endovenous treatments in therapy for lateral embryonic veins.

Huegel, Ulrike; Baumgartner, Iris (2019). Implementation of new endovenous treatments in therapy for lateral embryonic veins. Journal of vascular surgery cases and innovative techniques, 5(3), pp. 243-247. Elsevier 10.1016/j.jvscit.2018.12.016

Preview

Text 1-s2.0-S2468428719300164-main.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (904kB) | Preview

Klippel-Trénaunay syndrome is characterized by a persistent lateral embryonic vein. This so-called marginal vein has a large diameter causing venous stasis and venous hypertension because of the absence of valves along its entire length. The extensive diameter of the vein impedes successful treatment by sclerotherapy. Surgical removal is considered technically challenging for potential severe intraoperative blood loss due to the large perforators to the deep veins. Here we show that endovenous treatments (laser ablation, cyanoacrylate adhesive) might be feasible options in therapy for lateral embryonic veins.

Interest & Impact

Downloads

127 since deposited on 24 Jan 2020
42 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item